Transesophageal Echocardiography Transthoracic Echocardiography TAPSE

NCT ID: NCT06221384

Last Updated: 2024-07-30

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

82 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-02-01

Study Completion Date

2026-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Modified TAPSE (m-TAPSE) is a new method in which TAPSE is measured by taking the difference between the apical and lateral tricuspid annulus distance during diastole and systole. It can be measured using transesophageal echocardiography (TEE) in the mid-esophageal four-chamber (ME 4CH) view and is an alternative easily measurable parameter for intraoperative assessment of RV systolic function as long as optimal imaging quality is achieved.

In this prospective observational study, between 01.02.2024 and 01.01.2025, patients between the ages of 1-18 will undergo transcatheterization procedures using TTE and TEE under anesthesia by a pediatric cardiologist. TAPSE of these patients will be measured by TTE and TEE. TAPSE of the patients will be evaluated with TTE and TOE.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Modified TAPSE (m-TAPSE) is a new method in which TAPSE is measured by taking the difference between the apical and lateral tricuspid annulus distance during diastole and systole. It can be measured using transesophageal echocardiography (TEE) in the mid-esophageal four-chamber (ME 4CH) view and is an alternative easily measurable parameter for intraoperative assessment of RV systolic function as long as optimal imaging quality is achieved.

Our study will begin between 01.02.2024 and 01.01.2025 at Adnan Menderes University Practice and Research Hospital, after receiving the approval of the Ethics Committee of the patients. In this prospective observational study, it was planned to include all patients between the ages of 1 and 18 who underwent transcatheterization procedures using TTE and TEE under anesthesia by pediatric cardiologist. Written and verbal consent will be obtained from the parents/guardians of the patients. Patients will be anesthetized for transcatheter procedures and TAPSE and FAC values will be recorded during TTE and TEE echocardiography for the procedure. Two practitioners will make the measurements and each of their own values will be recorded. After the data collection process for the study is completed; The data will be compared statistically. TTE and TEE values of the patients will be compared among themselves.

All patients will undergo TEE and TTE under general anesthesia with an Echocardiography Device. The values of all parameters will be recorded by taking the average values of three cardiac cycle measurements. Measurement methods will be performed in accordance with the American Society of Echocardiography Guidelines. M-Mode, 2D images, color, pulse, Continuous Wave Doppler and Tissue Doppler measurements will be taken from all subjects complying with standard echocardiographic application methods. TAPSE will be calculated by placing an M-mode cursor across the Tricuspid Annulus and measuring the amount of longitudinal movement at peak systole.

m-TAPSE by TOE: m-TAPSE will be calculated as the 'difference between the apical to lateral tricuspid annular distance' during diastole and systole measured in the ME 4CH view. Within this cycle, the maximum and minimum dimensions will be obtained and the difference will be used to measure m-TAPSE. Longitudinal movement during systole will be measured by performing enhanced Doppler alignment with a modified transgastric RV inlet view and lower tricuspid annular motion.

End-diastolic area (EDA) and end-systolic area (ESA) are the FAC measurements that will be used in the TTE apical four-chamber view, while the same measurement will be made in the TEE four-chamber view, which also shows EDA and ESA.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

We Aim to Compare Modified Tricuspid Annular Plane Systolic Excursion With Tricuspid Annular Plane Systolic Excursion

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1- Hastanın 1-18 yaş arasında olması 2- Pediyatrik kardiyak transkataterizasyon işlemi yapılması 3- ASA 1-3 hastalar

Exclusion Criteria

* 1- Veli veya vasinin onay vermemesi 2- ASA 4 ve üzeri hastalar
Minimum Eligible Age

1 Year

Maximum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aydin Adnan Menderes University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ferdi gülaştı

assistant prof.dr.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ferdi Gülaştı

Aydin, , Turkey (Türkiye)

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ferdi Gülaştı

Role: primary

Ferdi Gülaştı

Role: backup

+905054929650

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.